Accessibility Menu
 
Hinge Health logo

Hinge Health

(NYSE) HNGE

Current Price$38.36
Market Cap$3.04B
Since IPO (2025)+3%
5 YearN/A
1 YearN/A
1 Month-14%

Hinge Health Financials at a Glance

Market Cap

$3.04B

Revenue (TTM)

$587.86M

Net Income (TTM)

$528.26M

EPS (TTM)

$-5.44

P/E Ratio

-7.08

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Price

$38.36

Volume

492,225.742

Open

$39.00

Previous Close

$38.49

Daily Range

$37.80 - $39.20

52-Week Range

$30.08 - $62.18

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hinge Health

Industry

Healthcare Providers and Services

Employees

143

CEO

Daniel Perez, PhD

Headquarters

San Francisco, CA 94105, US

HNGE Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

-92%

Net Income Margin

-90%

Return on Equity

-107%

Return on Capital

-1%

Return on Assets

-71%

Earnings Yield

-14.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.04B

Shares Outstanding

78.76M

Volume

492.23K

Short Interest

0.00%

Avg. Volume

1.27M

Financials (TTM)

Gross Profit

$468.22M

Operating Income

$546.37M

EBITDA

$541.24M

Operating Cash Flow

$171.44M

Capital Expenditure

$708.00K

Free Cash Flow

$170.73M

Cash & ST Invst.

$363.86M

Total Debt

$8.04M

Hinge Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$170.73M

+45.6%

Gross Profit

$144.03M

+49.9%

Gross Margin

84.36%

N/A

Market Cap

$3.04B

N/A

Market Cap/Employee

$2.01M

N/A

Employees

1,514

N/A

Net Income

$32.09M

+18.4%

EBITDA

$28.48M

+8.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$355.82M

-20.9%

Accounts Receivable

$66.06M

+55.5%

Inventory

$15.64M

-37.2%

Long Term Debt

$7.63M

-47.4%

Short Term Debt

$4.22M

-44.6%

Return on Assets

-70.93%

N/A

Return on Invested Capital

-1.42%

N/A

Free Cash Flow

$63.49M

+70.2%

Operating Cash Flow

$63.90M

+66.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OSCROscar Health, Inc.
$11.73+2.27%
DYNDyne Therapeutics, Inc.
$18.10-0.17%
VKTXViking Therapeutics, Inc.
$32.96+1.29%
INDVIndivior Pharmaceuticals Inc
$30.65+0.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About HNGE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.